Page last updated: 2024-08-18

xanthenes and Experimental Mammary Neoplasms

xanthenes has been researched along with Experimental Mammary Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's4 (33.33)18.2507
2000's5 (41.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akhurst, RJ; Babb, JS; Barcellos-Hoff, MH; Bouquet, F; Demaria, S; DeWyngaert, JK; Formenti, SC; Hann, B; Lonning, SM; Pal, A; Pilones, KA1
Lee, AE; McKeage, MJ; Pruijn, FB; Shalal-Zwain, S; Siim, BG; Wilson, WR1
Chakrabarti, S; Chakraborty, C; Lala, PK; Timoshenko, AV; Xu, G1
Condeelis, J; Kedrin, D; Sahai, E; Segall, JE; Wyckoff, J1
Baguley, BC; Cliffe, S; Hill, RP; Rutland, M; Taylor, ML; Wilson, WR1
Denny, WA; Lee, HH; Li, AE; Patterson, LH; Pullen, SM; Thompson, KM; Wilson, WR1
Holford, NH; Pruijn, FB; van Daalen, M; Wilson, WR1
Laux, WT; Palmer, BN; Rutland, MD; Siim, BG; Wilson, WR1
Horsman, MR; Murata, R; Overgaard, J; Siemann, DW1
Baguley, BC; Thomsen, LL; Wilson, WR1
Mestroni, G; Pacor, S; Sava, G; Zassinovich, G; Zorzet, S1
Leeper, DB; Park, CH; Rowley, R; Thakur, ML1

Other Studies

12 other study(ies) available for xanthenes and Experimental Mammary Neoplasms

ArticleYear
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Nov-01, Volume: 17, Issue:21

    Topics: Amino Acids; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Protein Serine-Threonine Kinases; Pyrazoles; Pyrroles; Radiation-Sensitizing Agents; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Transforming Growth Factor beta1; Xanthenes; Xenograft Model Antitumor Assays

2011
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones

2003
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Experimental cell research, 2003, Oct-01, Volume: 289, Issue:2

    Topics: Alprostadil; Animals; Breast Neoplasms; Carcinoma; Cell Movement; Colforsin; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Indoles; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Neoplasm Invasiveness; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Tumor Cells, Cultured; Up-Regulation; Xanthenes; Xanthones

2003
Imaging tumor cell movement in vivo.
    Current protocols in cell biology, 2007, Volume: Chapter 19

    Topics: Adenocarcinoma; Animals; Catheters, Indwelling; Cell Line, Tumor; Cell Movement; Female; Green Fluorescent Proteins; Humans; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Mice, Transgenic; Microscopy, Fluorescence, Multiphoton; Neoplasm Transplantation; Rats; Rats, Inbred F344; Transfection; Xanthenes

2007
Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid.
    International journal of radiation oncology, biology, physics, 1994, May-15, Volume: 29, Issue:2

    Topics: Aniline Mustard; Animals; Antineoplastic Agents; Drug Synergism; Female; Flavonoids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Regional Blood Flow; Tirapazamine; Triazines; Xanthenes; Xanthones

1994
Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.
    The British journal of cancer. Supplement, 1996, Volume: 27

    Topics: Acridines; Animals; Anthraquinones; Antineoplastic Agents; Cell Survival; Humans; Intercalating Agents; Mammary Neoplasms, Experimental; Mice; Nitracrine; Oxidation-Reduction; Prodrugs; Xanthenes; Xanthones

1996
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Cell Hypoxia; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; Xanthenes; Xanthones

1997
Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic
    Cancer research, 2000, Aug-15, Volume: 60, Issue:16

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Hypoxia; Fibrosarcoma; Humans; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Radiopharmaceuticals; Stilbenes; Xanthenes; Xanthones

2000
Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
    Radiation research, 2001, Volume: 156, Issue:5 Pt 1

    Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Sarcoma, Experimental; Xanthenes; Xanthones

2001
Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Flavonoids; Mammary Neoplasms, Experimental; Nitric Oxide; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xanthenes; Xanthones

1992
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:5

    Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Female; Kidney; Liver; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Organ Size; Organometallic Compounds; Rhodamines; Spleen; Structure-Activity Relationship; Time Factors; Xanthenes

1989
Radioiodinated rhodamine-123: preparation and preliminary evaluation as an agent for tumor scintigraphy.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:5

    Topics: Adenocarcinoma; Animals; Cricetinae; Female; Iodine Radioisotopes; Isotope Labeling; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitochondria; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Radionuclide Imaging; Rhodamine 123; Rhodamines; Sarcoma, Experimental; Tissue Distribution; Xanthenes

1988